Home
  • Choose country
  • Navigation
  • Contact
News

From our Newsletter

This page is dedicated to providing you with the latest articles from our lymphoedema newsletter. We hope that you find the news interesting and useful. Please share this page with your colleagues.

Lymphoedema Courses Now Available

You can find out which education route is right for you with the University of Glasgow. One of their lymphoedema courses might be what you are looking for to develop new skills and knowledge in lymphoedema management. 

To find out more please click here.

3rd Advanced Lymphoedema Specialist Event

Thank you to all the delegates that attended BSN medical’s 3rd Advanced Lymphoedema Specialist Event at the Park Regis Hotel in Birmingham this week. This engaging event included the launch of the revolutionary new JOBST® Relax custom-fit compression garment range for the management of lymphoedema at night and the delegates received a technical presentation from the designer of the product. This was preceded by an informative presentation from Justine Whitaker on the ‘Lymphoedema management at night: views from patients across five countries’ study that was published in the BJCN in October 2016 and provides an insight and understanding into the use of night-time compression in the management of lymphoedema from a patient perspective. Rebecca Elwell’s early product evaluation feedback on the use of JOBST Relax on two patients prompted lots of discussion. In support of the BLS Lymphoedema Awareness Week and the launch of this product, all delegates participated in ‘the big shleep over’ in their JOBST Relax garment, which provided valuable feedback in the management of lymphoedema.

Please click here to learn more information on JOBST Relax and click the clinical tab to read the article.

Dorset Lymphoedema Steering Group Event

A “Chronic Oedema Awareness Day” was held this week to help educate and raise awareness of lymphoedema / chronic oedema in the community, with a focus on; management of obesity-related chronic oedema, the compression garment choices available on FP10 and the local referral pathway.

The day was supported and sponsored by BSN medical Lymphoedema Development Manager Joe Emms and Account Manager Simon Rowles.

Genetics and Lymphoedema

The future of genetics is an evolving story, with new techniques that enable manipulation of DNA, and whether they may serve as a progressive means in re-writing this story.  However, genetics can be a confusing subject to navigate.  This comment piece summarises some of the key terms used within genetics, historical developments and how these relate to lymphoedema.

To find out more please click here.

References: Cooper, G. (2017) Genetics and lymphoedema: a future yet to be fully discovered. British Journal of Community Nursing, 22(1), pp. 646–648

Lymphoedema Awareness Week Begins!

The second day of the annual British Lymphology Society (BLS) Lymphoedema Awareness Week begins and many events are taking place up and down the country.

Today is also recognised as International Lymphoedema Awareness Day and around the world events are taking place to support awareness, research and education. 'Choose your Walk' is being supported by BSN medical USA. It follows on from the good work at last years event which featured Kathy Bates and friends, the well-known actress who lives with lymphoedema following breast cancer. To find out more click here.

To assist in raising lymphoedema awareness, BSN medical is dedicating a  newsletter to lymphoedema, with information that you will find interesting, as well as feedback on local awareness events. To keep up-to-date with the BLS activities please visit their website, click here.

BLS Conference 2017

The BLS has confirmed that Yarnfield Park Training and Conference Centre in Stone, Staffordshire is the new venue to host this two-day event.

Date for your diary: 1st - 3rd October

For further conference details and to submit an abstract click here.

What are the perceived barriers that prevent patients with lymphoedema from continuing optimal skin care?

Patient concordance and its impact upon treatment / management options is an area that creates debate amongst healthcare professionals and therapists.  This qualitative study focuses on the patient experience and how they live with lymphoedema.  It also considers how a patient feels about the need and therapeutic benefit in relation to skin care, and why they appear to be non-concordant. The results of this study recommend patients education and support to help influence patient understanding of the consequences of secondary complications and exacerbations of symptoms when skin care is not maintained.

To find out more please click here.

Reference: James, S. (2011) What are the perceived barriers that prevent patients with lymphoedema from continuing optimal skin care?', Wound Practice & Research, 19(3): 152-157. 

Commissioning Guidance for Lymphoedema Services for Adults Living With and Beyond Cancer

The political and economic environment has led to NHS service provision coming under greater scrutiny.  England has yet to develop national standards regarding the provision and structure of lymphoedema services.  However, work in London has led to a PAN London commissioning document that may have importance and impact beyond the capital.

This commissioning guidance document focuses on services for people with lymphoedema as a result of cancer treatment and sets out what a good service looks like, including patients with primary or secondary lymphoedema. This document which was endorsed last year by the Cancer Commissioning Board, provides a compelling account and strong economic reasoning to why there is a need to improve services.

To find out more please click here.

A review of the evidence for adjustable compression wrap devices

Adjustable compression wrap devices (ACWD) are a recognised effective treatment solution in the treatment of lymphatic and venous conditions.  This evidence review considers the clinical efficacy and the economic implications surrounding ACWD and concludes that claims against cost savings are compelling, alongside scope for improved quality of life for patients.

There is also recognition that further clinical research needs to be carried out in this area to better understand the long term nature of this treatment option.

To find out more please click here.

Reference: Williams, A. (2016) A review of the evidence for adjustable compression wrap devices ACWD

New Developments in Clinical Aspects of Lymphatic Disease

Research in lymphoedema is gaining pace and so is our understanding of the lymphatic system.  This article discusses some new developments in the understanding of the lymphatic system and its major functions. You can also read about the developments in understanding genetics related to primary lymphoedema. This clinical investigation concludes that more work needs to be carried out in this area. The hope is that with these developing technologies, in lymphatic science, there will be meaningful advances in the future.

To find out more please click here.

Reference: Mortimer, P., Rockson, S. (2014) New development in clinical aspects of lymphatic disease.  The Journal of Clinical Investigation. 124(3), pp.915-921

The Foeldi College in the UK

The Foeldi College, established in the 1980's, is one of the world's leading training providers for lymphoedema management and delivers exceptional levels of theoretical and practical based training.

In 2017 the Foeldi College is again coming to the UK with an educational programme covering basic, full therapy, and review courses in manual lymphatic drainage (MLD) / decongestive lymphatic therapy (DLT).

For more information on these courses and how to register please click here.

BLS - New Updated Guidelines

The BLS has recently issued updates to two key documents, supporting members with revised cellulitis guidelines and the benefits of using Amoxicillin over Flucloxacillin for the treatment of cellulitis in lymphoedema patients.

These documents are available in the members area of the BLS website www.bls.com or simply by clicking on the link below.

National Lymphoedema Conference 2017

We are pleased to announce that BSN medical will be attending the National Lymphoedema Conference in London on the 2nd March 2017.

The focus of the event is “Considering the physical and psychological impact of lymphoedema”.

Now in its fourth year and with the full backing of the British Lymphology Society (BLS) and Lipoedema UK, this conference benefits from a very strong and enticing programme aimed at attracting Lymphoedema Clinical Nurse Specialists, Community Nurses and Nurse Specialists interested in new and progressive treatments in lymphoedema management. The British Journal of community Nursing (BJCN) have partnered with the BLS for this conference to ensure current topics are incorporated into the programme, making it fresh and up-to-date. Speakers include Alex Munnoch, Jane Wigg, Denise Hardy and Dr Karen Robb.

Manual lymphatic drainage (MLD) for lymphoedema following breast cancer

This systematic review undertaken by the Cochrane collaboration, was to assess the efficacy and safety of MLD in treating breast cancer related lymphoedema (BCRL). The review searched a number of databases which resulted in six studies being reviewed. The studies looked at MLD and compression treatments. The results of the review suggest MLD is safe and may offer greater benefit in addition to compression treatments, particularly when treating mild to moderate BCRL. Trials with an armsleeve had volumetric inconsistencies therefore further research is required. Despite these inconsistences 60-80% of participants felt better (reduction in pain and heaviness) regardless of which treatment was received. Additional outcomes are also included within this study and it is worth reading the full systematic review.

To find out more please click here.

References: Manheimer, E et al. (2015) Manual lymphatic drainage for lymphoedema following breast cancer (Review). London: Cochrane database.

Associations between the treatment and outcomes of patients with upper and lower limb lymphoedema in Japan: a cross-sectional observational study

This cross-sectional study took place in Japan with the objective of examining the association between lymphoedema treatments and outcomes. Lymphoedema outpatient clinics were the setting with a total of 170 patients participating in the study.  Data collection involved medical records, physical assessments and interviews. Results from the study suggest that secondary lymphoedema was present in 92.9%, with 53.8% of this figure represented by lower limb conditions.  Patients using compression garments were 2.85 times more likely to be satisfied with their treatment compared to those not using compression garments (p<0.01).   Patients receiving simple lymphatic drainage (SLD) exhibited a greater level of satisfaction compared to those not in receipt of SLD (p<0.01). It was also noted that patients quality of life (QOL) was higher in those receiving complete decongestive therapy (CDT) compared to those not in receipt of CDT.

To find out more please click here.

References: Luchi, T. et al (2015)Associations between the treatment and outcomes of patients with upper and lower lymphoedema in Japan: A cross-sectional observational study. London: International Journal of Nursing Studies, 52, pp.913-919.

Contacts

BSN medical Limited
Block C Willerby Hill Business Park
Willerby
Hull
East Yorkshire
HU10 6FE
UK

 


 Tel: +44 (0) 1482 670100
 Fax: +44 (0) 1482 670111

orders.uk@bsnmedical.com